Investment Analysts’ Price Target Changes for August 8th (ACAD, ADUS, ASLE, BAM, BGNE, BMBL, CART, CE, CSGS, DT)

Investment Analysts’ price target changes for Thursday, August 8th: ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target reduced by Citigroup Inc. from $30.00 to $23.00. They currently have a buy rating on the stock. Addus HomeCare (NASDAQ:ADUS) had its target price raised by Royal Bank of Canada from $129.00 to $141.00. They currently have an outperform […]

Leave a Reply

Your email address will not be published.

Previous post Guardant Health (NASDAQ:GH) Shares Gap Down to $33.96
Next post Ticker: Stocks rally on job claims report; Third person dies in Boar’s Head listeria outbreak